Schwabe Pharma - Kaloba Cough & Cold Relief Syrup - Pelargonium Sidoides Root Extract - Traditionally Used for Common Cold, Runny Nose, Sore Throat, Blocked Nose, Cough - Sugar Free – 100ml

Product Information

Although there are no data on cases of overdose, overdose is likely to increase side-effects. Thus, treatment should be symptomatic and as clinically indicated. 5. Pharmacological properties 5.1 Pharmacodynamic properties In rare cases (≥ 1/10,000 to ≤ 1/1,000) mild bleeding from the gums or nose may occur. Furthermore, hypersensitivity reactions (e.g. exanthema, urticaria, pruritus of skin and mucous membranes) have been described in rare cases. Such reactions may occur after the first intake of the product. Do not dispose of medicines in waste water or household waste. Ask your pharmacist how to dispose of the medicine when you stop using it. In doing so, they contribute to the protection of the environment. Special notes on the content Gastro-intestinal complaints such as stomach pain, heartburn, nausea, vomiting, difficulty swallowing (dysphagia) or diarrhoea. Rare side-effects (affecting more than 1 in 10,000 but fewer than 1 in 1000 people) Bao Y, Gao Y, Koch E, Pan X, Jin Y, Cui X. Evaluation of pharmacodynamic activities of EPs(R) 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis. Phytomedicine. 2015;22(4):504–9.

The measuring cup has markings. Please open the bottle and slowly fill the measuring cup to the required amount in millilitres (ml). Joos S, Glassen K, Musselmann B. Herbal medicine in primary healthcare in Germany: the Patient's perspective. Evid Based Complement Alternat Med. 2012;2012:10. Kaloba is an orange to light brown, viscous syrup. 4. Clinical particulars 4.1 Therapeutic indications Treatment of children under 6 years of age should only be carried out after consultation with a doctor. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet (London, England). 2005;365(9459):579–87.

Pharmacy product

The necessary amount of drops may be taken directly from a spoon or, if preferred, can be mixed with half a glass of water and the contents of the entire glass should be drunk straightaway. A. It is a common name for the roots of the herb pelargonium sidoides and pelargonium reniforme curt. The preparations of this herb root are obtained by putting them in a solvent like ethanol and then dissolving compounds to form a liquid extract for utilisation. Q. How do you prepare geranium tea? No studies on the effects on the ability to drive and use machines have been performed. 4.8 Undesirable effects The extract (EPs® 7630) used in the herbal medicinal product (Kaloba® manufactured by Dr. Willmar Schwabe GmbH & Co. KG, Germany) is classified by the European Pharmacopoeia as “other extract” and therefore not adjusted to a particular content of constituents. Independent of this formal classification, the constituents of this herbal active ingredient have been described in detail [ 36]. Approximately 80% m/m of the extract are assigned to six major groups of constituents, oligomeric prodelphinidines (commonly designated in this context as polyphenols) being the most significant group (approximately 40% of the dried extract).

Kaloba syrup is an orange to light brown syrup. However it is a natural product and therefore slight variations in colour and taste may occur. This product also contains the following ingredients: Tablet core: Maltodextrin, microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, precipitated silica, magnesium stearate. Baars EW, Zoen EBV, Breitkreuz T, Martin D, Matthes H, Schoen-Angerer TV, et al. The Contribution of Complementary and Alternative Medicine to Reduce Antibiotic Use: A Narrative Review of Health Concepts, Prevention, and Treatment Strategies. Evidence-based Complementary and Alternative Medicine. 2019;2019 (no pagination).

5. Pharmacological properties

Although patients suggested changes to the severity of illness rating scale and to the EQ-5D-5L, it will not be possible to make these changes in future trials because these scales are only validated in their current format. Restrictions on which type of contraception were used by women were stringent and were misunderstood by some of the GPs enrolling patients. Implications for further research